CAMP and Cowden disease: Furthermore, the fact that cathelicidin supplementation mirrors the effects of calcitriol on macrophage-mediated inflammation and enterocyte oxidative stress suggests that LL-37 could be a therapeutic option for the suppression of CD inflammatory symptoms.